Related Experiment Video
Updated: Feb 28, 2026

07:41
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
9.7K
Increasing the efficiency of oncology basket trials using a Bayesian approach
Rong Liu1, Zheyu Liu1, Mercedeh Ghadessi1
1Bayer Healthcare LLC, Whippany, NJ 07981, USA.
Contemporary Clinical Trials
|June 21, 2017
Summary
This study introduces a new statistical method for oncology basket trials. It improves efficiency by borrowing information between similar tumor types, requiring fewer patients or achieving higher power.
Area of Science:
- Oncology
- Biostatistics
- Clinical Trial Design
Background:
- Targeted and immune-oncology therapies necessitate advanced statistical designs for early-phase oncology trials.
- Basket trials evaluate drugs across multiple tumor types with shared biological targets, but often analyze indications independently, missing potential similarities.
Purpose of the Study:
- To develop and evaluate a novel statistical methodology for enhancing oncology basket trials.
- To improve trial efficiency and power by leveraging biological similarities among different indications.
Main Methods:
- Proposes an interim analysis to assess response rate homogeneity across indications.
- Employs Bayesian hierarchical modeling in the second stage for indications with similar response rates.
- Utilizes simulation studies to quantify efficiency gains compared to conventional parallel designs.
Main Results:
- The proposed method increases study power by enabling information sharing between indications with similar response rates.
- Efficiency gains are substantial when response rates are comparable across most indications.
- The method demonstrates improved performance over conventional approaches even when response rates vary considerably.
Conclusions:
- The Bayesian hierarchical modeling approach enhances oncology basket trials by pooling information from similar indications.
- This methodology offers a more flexible and efficient design for evaluating novel cancer therapies.
- The approach provides a statistically robust framework for adaptive trial designs in precision oncology.
Related Concept Videos
Cancer Survival Analysis
805
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
805
Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
503
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
503
Kaplan-Meier Approach
663
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
663

